e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Methodological aspects of asthma and COPD epidemiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of pulmonary function stratifies global coronary heart disease risk
H. M. Lee, H. Le, B. T. Lee, N. D. Wong (Irvine, United States Of America)
Source:
Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Session:
Methodological aspects of asthma and COPD epidemiology
Session type:
Thematic Poster Session
Number:
1003
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. M. Lee, H. Le, B. T. Lee, N. D. Wong (Irvine, United States Of America). Assessment of pulmonary function stratifies global coronary heart disease risk. Eur Respir J 2009; 34: Suppl. 53, 1003
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013
Heart failure and coronary artery disease in lung disease
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
Evaluation of pulmonary functions in valvular heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017
Year: 2018
Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients
Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
Year: 2020
Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015
Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept